A detailed history of Kepos Capital LP transactions in Johnson & Johnson stock. As of the latest transaction made, Kepos Capital LP holds 249 shares of JNJ stock, worth $41,040. This represents 0.01% of its overall portfolio holdings.

Number of Shares
249
Previous 271 8.12%
Holding current value
$41,040
Previous $43,000 16.28%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $3,176 - $3,471
-22 Reduced 8.12%
249 $36,000
Q1 2024

May 10, 2024

SELL
$155.22 - $162.74 $310 - $325
-2 Reduced 0.73%
271 $43,000
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $1,892 - $2,065
-13 Reduced 4.55%
273 $43,000
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $4,672 - $5,234
30 Added 11.72%
286 $45,000
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $308 - $332
2 Added 0.79%
256 $42,000
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $40,690 - $45,666
254 New
254 $45,000
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $400,477 - $459,968
-3,141 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $398,749 - $446,461
3,141 New
3,141 $406,000
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $2.43 Million - $2.67 Million
-18,517 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $4.09 Million - $4.55 Million
-32,556 Reduced 63.74%
18,517 $2.59 Million
Q4 2018

Feb 13, 2019

BUY
$122.84 - $147.84 $302,677 - $364,277
2,464 Added 5.07%
51,073 $6.59 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $49,483 - $58,152
-407 Reduced 0.83%
48,609 $6.72 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $1.2 Million - $1.32 Million
10,021 Added 25.7%
49,016 $5.95 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $4.88 Million - $5.78 Million
38,995 New
38,995 $5 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $1.03 Million - $1.13 Million
-7,879 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $1.02 Million - $1.07 Million
7,879
7,879 $1.02 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Kepos Capital LP Portfolio

Follow Kepos Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Kepos Capital LP with notifications on news.